Efficacy and Safety Study of Neramexane to Treat Congenital and Acquired Nystagmus

Summary

The purpose of this study is to investigate the safety and efficacy of neramexane mesylate in the treatment of congenital idiopathic nystagmus (CIN) in comparison to placebo. In addition, a subgroup of multiple sclerosis (MS) patients suffering from acquired nystagmus will be included; this subgroup will be analyzed in an exploratory manner only.

Timeline

Start

2008-05

Primary completion

—

Completion

—

Drugs

Indications